Abstract:ABSTRACT We recently found that a new pathogenic chimeric simian-human immunodeficiency virus (SHIV) elicited heterologous human immunodeficiency virus type-1 (HIV-1) neutralizing antibodies (nAbs) in therapy-naïve young rhesus macaques (RMs) following neonatal SHIV infection. Moreover, a subset of the SHIV-infected young RMs spontaneously controlled viremia. Here we evaluated humoral and cellular immunity and plasma biomarkers associated with spontaneous viremia suppression in a new model of young SHIV-infected RMs that generated heterologous HIV-1 nAbs independent of viremia control to gain insights into pediatric immunity that may be harnessed by appropriate therapies in HIV-1-infected infants and children. We determined the levels of 31 plasma analytes (cytokines, chemokines, and growth factors) in SHIV-infected RMs over the course of infection and found that six analytes with chemoattractant or pro-inflammatory activities had significantly lower levels in plasma of RMs that controlled viremia compared to non-controllers. Single-cell transcriptomics of blood-derived immune cells demonstrated that RMs with viremia control had upregulated genes associated with immune activation and cytotoxic functions, whereas non-controllers had upregulated genes associated with immune cell exhaustion and dysfunction. In addition to CD8 T and natural killer cells, monocytes with upregulation of inhibitory genes previously reported only in cytotoxic cells constituted the immunologic environment associated with viremia suppression. These data implicated a complex immunologic milieu of viremia suppression that is not fully defined in pediatric subjects. Understanding immune cell subsets that may be harnessed to control viremia will provide insights into future designs of HIV-1 therapeutic strategies. IMPORTANCE Despite the advent of highly active anti-retroviral therapy, people are still dying from HIV-related causes, many of whom are children, and a protective vaccine or cure is needed to end the HIV pandemic. Understanding the nature and activation states of immune cell subsets during infection will provide insights into the immunologic milieu associated with viremia suppression that can be harnessed via therapeutic strategies to achieve a functional cure, but these are understudied in pediatric subjects. We evaluated humoral and adaptive host immunity associated with suppression of viremia in rhesus macaques infected soon after birth with a pathogenic SHIV. The results from our study provide insights into the immune cell subsets and functions associated with viremia control in young macaques that may translate to pediatric subjects for the design of future anti-viral strategies in HIV-1-infected infants and children and contribute to an understudied area of HIV-1 pathogenesis in pediatric subjects.

RETRACTED: Gc1qr Expression in Chimpanzees with Resolved and Chronic Infection: Potential Role of HCV Core/gc1qr-Mediated T Cell Suppression in the Outcome of HCV Infection

In vivo adaptation of hepatitis C virus in chimpanzees for efficient virus production and evasion of apoptosis

Hypervariable Region 1 Sequence Stability During Hepatitis C Virus Replication in Chimpanzees.

Dynamics of Acute Hepatitis B Virus Infection in Chimpanzees.

Early Env-specific CTLs Effectively Suppress Viral Replication in SHIV Controller Macaques

Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)

Cell-Mediated Immune Proliferative Responses to Hiv-1 of Chimpanzees Vaccinated with Different Vaccinia Recombinant Viruses

Hepatitis C Virus: Immunosuppression by Complement Regulatory Pathway

CD4+ T cell depletion does not affect the level of viremia in chronically SHIVSF162P3N-infected Chinese cynomolgus monkeys

HCV Core Protein Induces Chemokine CCL2 and CXCL10 Expression Through NF-κB Signaling Pathway in Macrophages.

Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice

Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice

Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host Restriction

Host immunity associated with spontaneous suppression of viremia in therapy-naïve young rhesus macaques following neonatal SHIV infection

HCV Core Protein Binds to Gc1qr to Induce A20 Expression and Inhibit Cytokine Production Through MAPKs and NF-κB Signaling Pathways

Preferential CTL targeting of Gag is associated with relative viral control in long-term surviving HIV-1 infected former plasma donors from China

Concerted synergy between viral-specific IgG and CD8+ T cells is critical for clearance of an HCV-related rodent hepacivirus

Different Proliferative Response of Human and Chimpanzee Lymphocytes after Contact with Human Immunodeficiency Virus Type 1 Gp120

SOCS1 and SOCS3 Are Targeted by Hepatitis C Virus Core/gC1qR Ligation to Inhibit T-Cell Function

CTL-mediated Immunotherapy Can Suppress SHIV Rebound in ART-free Macaques.

The T Cell Receptor Gene Usage By Simian Immunodeficiency Virus Gag-Specific Cytotoxic T Lymphocytes In Rhesus Monkeys